117 related articles for article (PubMed ID: 33124722)
1. The Fabp5/calnexin complex is a prerequisite for sensitization of mice to experimental autoimmune encephalomyelitis.
Paskevicius T; Jung J; Pujol M; Eggleton P; Qin W; Robinson A; Gutowski N; Holley J; Smallwood M; Newcombe J; Zochodne D; Chen XZ; Tang J; Kraus A; Michalak M; Agellon LB
FASEB J; 2020 Dec; 34(12):16662-16675. PubMed ID: 33124722
[TBL] [Abstract][Full Text] [Related]
2. Calnexin is necessary for T cell transmigration into the central nervous system.
Jung J; Eggleton P; Robinson A; Wang J; Gutowski N; Holley J; Newcombe J; Dudek E; Paul AM; Zochodne D; Kraus A; Power C; Agellon LB; Michalak M
JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515033
[TBL] [Abstract][Full Text] [Related]
3. Fatty Acid-Binding Protein 5 Facilitates the Blood-Brain Barrier Transport of Docosahexaenoic Acid.
Pan Y; Scanlon MJ; Owada Y; Yamamoto Y; Porter CJ; Nicolazzo JA
Mol Pharm; 2015 Dec; 12(12):4375-85. PubMed ID: 26455443
[TBL] [Abstract][Full Text] [Related]
4. Fatty Acid-Binding Protein 5 Mediates the Uptake of Fatty Acids, but not Drugs, Into Human Brain Endothelial Cells.
Lee GS; Pan Y; Scanlon MJ; Porter CJH; Nicolazzo JA
J Pharm Sci; 2018 Apr; 107(4):1185-1193. PubMed ID: 29247738
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid binding protein (Fabp) 5 interacts with the calnexin cytoplasmic domain at the endoplasmic reticulum.
Jung J; Wang J; Groenendyk J; Lee D; Michalak M; Agellon LB
Biochem Biophys Res Commun; 2017 Nov; 493(1):202-206. PubMed ID: 28911862
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone Increases Blood-Brain Barrier Expression of Fatty Acid-Binding Protein 5 and Docosahexaenoic Acid Trafficking into the Brain.
Low YL; Jin L; Morris ER; Pan Y; Nicolazzo JA
Mol Pharm; 2020 Mar; 17(3):873-884. PubMed ID: 31944767
[TBL] [Abstract][Full Text] [Related]
7. Fatty Acid-Binding Protein 5 at the Blood-Brain Barrier Regulates Endogenous Brain Docosahexaenoic Acid Levels and Cognitive Function.
Pan Y; Short JL; Choy KH; Zeng AX; Marriott PJ; Owada Y; Scanlon MJ; Porter CJ; Nicolazzo JA
J Neurosci; 2016 Nov; 36(46):11755-11767. PubMed ID: 27852782
[TBL] [Abstract][Full Text] [Related]
8. Dietary docosahexaenoic acid supplementation enhances expression of fatty acid-binding protein 5 at the blood-brain barrier and brain docosahexaenoic acid levels.
Pan Y; Morris ER; Scanlon MJ; Marriott PJ; Porter CJH; Nicolazzo JA
J Neurochem; 2018 Jul; 146(2):186-197. PubMed ID: 29582413
[TBL] [Abstract][Full Text] [Related]
9. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
10. Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo.
Tietz SM; Engelhardt B
J Vis Exp; 2019 Mar; (145):. PubMed ID: 30985749
[TBL] [Abstract][Full Text] [Related]
11. A novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse models.
Cheng A; Jia W; Kawahata I; Fukunaga K
EBioMedicine; 2021 Oct; 72():103582. PubMed ID: 34624687
[TBL] [Abstract][Full Text] [Related]
12. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
[TBL] [Abstract][Full Text] [Related]
13. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
[TBL] [Abstract][Full Text] [Related]
14. Interferon-γ safeguards blood-brain barrier during experimental autoimmune encephalomyelitis.
Ni C; Wang C; Zhang J; Qu L; Liu X; Lu Y; Yang W; Deng J; Lorenz D; Gao P; Meng Q; Yan X; Blasig IE; Qin Z
Am J Pathol; 2014 Dec; 184(12):3308-20. PubMed ID: 25307346
[TBL] [Abstract][Full Text] [Related]
15. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
[TBL] [Abstract][Full Text] [Related]
16. B7-H1 shapes T-cell-mediated brain endothelial cell dysfunction and regional encephalitogenicity in spontaneous CNS autoimmunity.
Klotz L; Kuzmanov I; Hucke S; Gross CC; Posevitz V; Dreykluft A; Schulte-Mecklenbeck A; Janoschka C; Lindner M; Herold M; Schwab N; Ludwig-Portugall I; Kurts C; Meuth SG; Kuhlmann T; Wiendl H
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6182-E6191. PubMed ID: 27671636
[TBL] [Abstract][Full Text] [Related]
17. Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis.
Liu L; Huang D; Matsui M; He TT; Hu T; Demartino J; Lu B; Gerard C; Ransohoff RM
J Immunol; 2006 Apr; 176(7):4399-409. PubMed ID: 16547278
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.
Cheng Z; Zhang J; Liu H; Li Y; Zhao Y; Yang E
Drug Metab Dispos; 2010 Aug; 38(8):1355-61. PubMed ID: 20427691
[TBL] [Abstract][Full Text] [Related]
19. Chemokine CCL17 is expressed by dendritic cells in the CNS during experimental autoimmune encephalomyelitis and promotes pathogenesis of disease.
Ruland C; Renken H; Kuzmanov I; Fattahi Mehr A; Schwarte K; Cerina M; Herrmann A; Otte DM; Zimmer A; Schwab N; Meuth SG; Arolt V; Klotz L; Förster I; Scheu S; Alferink J
Brain Behav Immun; 2017 Nov; 66():382-393. PubMed ID: 28642092
[TBL] [Abstract][Full Text] [Related]
20. The anti-inflammatory effect of donepezil on experimental autoimmune encephalomyelitis in C57 BL/6 mice.
Jiang Y; Zou Y; Chen S; Zhu C; Wu A; Liu Y; Ma L; Zhu D; Ma X; Liu M; Kang Z; Pi R; Peng F; Wang Q; Chen X
Neuropharmacology; 2013 Oct; 73():415-24. PubMed ID: 23831366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
